Caleb Lusk
Addiction Medicine · San Pedro, CANPI 1386149912
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Gilead accounts for 77.2% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $4,997 and has fallen 72.6% since, to $1,371 in 2025. Among addiction medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $69.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$6K
- AbbVie$539
- Viiv Healthcare Company$231
- Novo Nordisk$106
- Indivior Inc.$100
- Amgen$97
- plus $603 from 15 others
What the payments were for
- Consulting fees$3,21044%
- Travel & lodging$1,27117%
- Food & beverage$2,85739%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 41 | $5,663 |
| AbbVie | 21 | $539 |
| Viiv Healthcare Company | 7 | $231 |
| Novo Nordisk | 5 | $106 |
| Indivior Inc. | 3 | $100 |
| Amgen | 4 | $97 |
| Braeburn Inc. | 3 | $85 |
| Exact Sciences | 3 | $81 |
| Sanofi Pasteur Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $68 |
| Hologic Sales And Service, LLC | 2 | $49 |
| Pfizer | 2 | $41 |
| Potrero Medical, Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $28 |
| Sage Therapeutics, LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Masimo Corporation | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Optinose US, Inc. | 1 | $22 |
| Reprise Biomedical, Inc. | 1 | $19 |
| Coopersurgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epclusa$4,728
How this compares
$7,338 in reported general payments places this provider in the 95th percentile of 190 addiction medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VascepaIcosapent Ethyl | 11 | $5,399 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $3,434 |
| Atorvastatin Calcium | 57 | $521 |
| Diclofenac Sodium | 13 | $298 |
| Metformin Hcl | 25 | $206 |
| Losartan Potassium | 13 | $190 |
| Lisinopril | 21 | $142 |
| Fluticasone Propionate | 16 | $120 |
| Tamsulosin Hcl | 11 | $114 |
| Amlodipine Besylate | 17 | $83 |
| Hydrochlorothiazide | 17 | $57 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in San Pedro
- Tipu KhanVentura$262K
- Anthony AlbaneseMather$135K
- Matthew TorringtonCulver City$77K
- Kenneth StarrArroyo Grande$64K
- Drew PinskySouth Pasadena$60K
- Mark HonzelBeverly Hills$27K
- Bryan HylerVista$17K
- Abraham MalkinLos Angeles$12K
- Jonathan ReitmanBeverly Hills$11K
- Faried BanimahdSanta Ana$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.